Erlotero 150 Mg Tablets

Product Description

Erlotero 150mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.  You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.  It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.

Advanced EGFR Inhibition

Erlotero 150 mg Tablets work by targeting the epidermal growth factor receptor (EGFR), effectively slowing cancer cell growth in non-small cell lung and pancreatic cancers. As an allopathic oral therapy, it provides an essential treatment option for eligible adult patients.


Strict Prescription and Monitoring

This medication is available by prescription only and demands regular medical monitoring, particularly in patients with liver or kidney concerns. Using Erlotero during pregnancy or breastfeeding is not recommended. Always follow your oncologist's guidance for optimal benefit and safety.


Proper Storage and Administration

Preserve the quality and effectiveness of Erlotero by storing it below 30C and keeping it away from light and moisture. The tablets are designed for oral administration-do not crush or chew-and must be taken precisely as instructed by your healthcare provider.